socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Tuesday, July 26, 2005

    Nanogen Invests In Gene Marker Company
    San Diego-based Nanogen announced this morning that it has made an investment in Jurilab Ltd., a Finnish company that focuses on the discovery and identification of new genes and gene markers. The investment gives Nanogen rights to develop diagnostic products based on the genes and gene markers discovered by Jurilab. The company said that the initial efforts will be on cardiovascular and metabolic diseases, including adult onset diabetes. The investment is worth $1.25M euros for less than a 20% equity interest, and a provision for full acquisition of Jurilab at Nanogen's election.
    posted on Tuesday, July 26, 2005

    Related companies:
    Nanogen

    Related stories:
    > Nanogen Cuts Business Line, Staff
    > Nanogen Cuts Staff
    > Genetronics Acquires Gene Therapy Firm
    > Invitrogen Licenses Gene Synthesis Service
    > Interview with Gene Alexander, MaMoCa

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Friday, September 5, 2008
    Thursday, September 4, 2008
    Wednesday, September 3, 2008
    Tuesday, September 2, 2008
    Friday, August 29, 2008